Good morning :)
Place Order
Add to Watchlist

Nureca Ltd

NURECA Share Price

305.500.05% (-0.15)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Health Care
Pharmaceuticals
Smallcap

With a market cap of ₹305 cr, stock is ranked 2,225

High Risk

Stock is 4.73x as volatile as Nifty

NURECA Stock Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

Avg

Average profitability - not good, not bad

Entry point

Avg

The stock is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

Health Care
Pharmaceuticals
Smallcap

With a market cap of ₹305 cr, stock is ranked 2,225

High Risk

Stock is 4.73x as volatile as Nifty

NURECA Performance & Key Metrics

NURECA Performance & Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
74.881.57—
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
36.875.820.59%

NURECA Analyst Ratings & Forecast

—
Analyst Ratings data is currently unavailable for this stock

Price Upside

Earnings Growth

Rev. Growth

NURECA Company Profile

Nureca Ltd is engaged in the marketing of home healthcare & wellness products

NURECA Similar Stocks (Peers)

Compare with peers Compare with peers 

NURECA Similar Stocks (Peers)

Compare with peers Compare with peers 
Sun Pharmaceutical Industries Ltd
SUNPHARMA
PE Ratio
39.63
39.63
1Y Return
0.45%
0.45%
Buy Reco %
91.67
91.67
Torrent Pharmaceuticals Ltd
TORNTPHARM
PE Ratio
67.04
67.04
1Y Return
12.63%
12.63%
Buy Reco %
76.92
76.92
Cipla Ltd
CIPLA
PE Ratio
23.30
23.30
1Y Return
1.51%
1.51%
Buy Reco %
70.00
70.00
Dr Reddy's Laboratories Ltd
DRREDDY
PE Ratio
18.77
18.77
1Y Return
2.85%
2.85%
Buy Reco %
41.94
41.94
Lupin Ltd
LUPIN
PE Ratio
29.21
29.21
1Y Return
1.24%
1.24%
Buy Reco %
72.22
72.22
Compare with Peers

NURECA Forecast

NURECA Forecasts

empty forecast

Forecast data is currently unavailable

Forecast data is currently unavailable

Price

Price Upside

Revenue

Revenue Growth

Earnings

Earnings Per Share

NURECA

NURECA

Income

Balance Sheet

Cash Flow

NURECA Income Statement

NURECA Income Statement

Industry refers to the sub-sector this company belongs to.
Lower than Industry Revenue Growth
A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of 4.18%, vs industry avg of 10.04%

Decreasing Market Share
Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share decreased from 0.04% to 0.03%

Lower than Industry Net Income
Net income is equal to net earnings (profit) less expenses. This number is an important measure of how profitable the company is

Over the last 5 years, net income has grown at a yearly rate of -33.04%, vs industry avg of 20.02%

Loading...

Financial YearFY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025TTM
Total Revenue20.0761.9999.49216.27263.25118.43102.44122.10138.48
Raw Materialssubtract15.6850.1667.49120.01159.5544.7656.2374.97130.23
Power & Fuel Costsubtract0.020.040.010.160.200.130.18
Employee Costsubtract0.893.164.589.9116.0612.2015.31
Selling & Administrative Expensessubtract11.1219.6644.8151.7130.3424.9130.25
Operating & Other expensessubtract-9.35-0.61-17.50-21.2934.978.67-3.51
Depreciation/Amortizationsubtract0.010.060.370.421.482.392.362.342.13
Interest & Other Itemssubtract0.060.240.771.600.740.450.491.211.51
Taxes & Other Itemssubtract1.212.612.2215.9616.02-2.49-0.750.490.53
EPS0.64891.43912.8692.1144.97-8.25-1.800.864.08
DPS—0.000.002.003.000.000.000.000.00
Payout ratio0.000.000.000.020.070.000.000.000.00
See Costs

EPS and DPS in ₹. Other numbers except Payout Ratio in ₹ cr

NURECA Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2024FY 2024

Annual report

PDF

Investor Presentation

Aug 10PDF
FY 2023FY 2023

Annual report

PDF
FY 2022FY 2022

Annual report

PDF
FY 2021FY 2021

Annual report

PDF
 

NURECA Stock Peers

NURECA Past Performance & Peer Comparison

NURECA Past Performance & Peer Comparison

Comparing 3 stocks from 
Health CarePharmaceuticals

Valuation

Technical

Forecast

ScreenerCompare valuation on Screener

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Nureca Ltd355.241.57—
Sun Pharmaceutical Industries Ltd39.635.980.89%
Torrent Pharmaceuticals Ltd67.0416.880.85%
Cipla Ltd23.303.931.05%

NURECA Stock Price Comparison

Compare NURECA with any stock or ETF
Compare NURECA with any stock or ETF
NURECA
Loading...

NURECA Holdings

NURECA Shareholdings

NURECA Promoter Holdings Trend

NURECA Promoter Holdings Trend

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

NURECA Institutional Holdings Trend

NURECA Institutional Holdings Trend

Increased Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has increased by 1.11%

Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

NURECA Shareholding Pattern

NURECA Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding64.97%0.00%0.04%0.07%34.92%

Dec 2024

Mar 2025

Jun 2025

Sep 2025

NURECA Shareholding History

NURECA Shareholding History

JunSepDec '24MarJunSep0.07%0.69%0.36%1.07%0.07%0.07%

NURECA Insider Trades & Bulk Stock Deals

NURECA Insider Trades & Bulk Stock Deals

Loading...

smallcases containing NURECA stock

smallcases containing NURECA stock

Looks like this stock is not in any smallcase yet.

NURECA Events

NURECA Events

NURECA Dividend Trend

No dividend trend available

Dividends

Corp. Actions

Announcements

Legal Orders

NURECA Dividend Trend

No dividend trend available

NURECA Upcoming Dividends

NURECA Upcoming Dividends

No upcoming dividends are available

NURECA Past Dividends

NURECA Past Dividends

Cash Dividend

Ex DateEx DateFeb 24, 2022

Interim
Interim | Div/Share: ₹3.00

Dividend/Share

₹3.00

Ex DateEx Date

Feb 24, 2022

Cash Dividend

Ex DateEx DateSep 21, 2021

Final
Final | Div/Share: ₹2.00

Dividend/Share

₹2.00

Ex DateEx Date

Sep 21, 2021

NURECA Stock News & Opinions

NURECA Stock News & Opinions

Corporate
Nureca board approves buyback of shares aggregating Rs 19.14 cr

The board of Nureca at its meeting held on 28 November 2025 has approved buyback of 5.80 lakh equity shares of the company at a price of Rs 330 for an aggregate amount of Rs 19.14 crore. Powered by Capital Market - Live

1 week agoCapital Market - Live
Corporate
Nureca fixes record date for buyback of shares

Nureca has fixed 12 December 2025 as record date for buyback of equity shares. Powered by Capital Market - Live

1 week agoCapital Market - Live
Corporate
Nureca to consider Buyback

Nureca will hold a meeting of the Board of Directors of the Company on 28 November 2025.Powered by Capital Market - Live

1 week agoCapital Market - Live
Corporate
Nureca to hold board meeting

Nureca will hold a meeting of the Board of Directors of the Company on 10 November 2025.Powered by Capital Market - Live

1 month agoCapital Market - Live
Earnings
Nureca reports consolidated net profit of Rs 3.63 crore in the September 2025 quarter

Net profit of Nureca reported to Rs 3.63 crore in the quarter ended September 2025 as against net loss of Rs 0.48 crore during the previous quarter ended September 2024. Sales rose 21.00% to Rs 37.74 crore in the quarter ended September 2025 as against Rs 31.19 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales37.7431.19 21 OPM %8.66-7.57 - PBDT5.130.55 833 PBT4.60-0.08 LP NP3.63-0.48 LP Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Nureca to hold board meeting

Nureca will hold a meeting of the Board of Directors of the Company on 16 October 2025.Powered by Capital Market - Live

1 month agoCapital Market - Live
Earnings
Nureca consolidated net profit declines 51.20% in the June 2025 quarter

Net profit of Nureca declined 51.20% to Rs 0.81 crore in the quarter ended June 2025 as against Rs 1.66 crore during the previous quarter ended June 2024. Sales rose 68.62% to Rs 34.18 crore in the quarter ended June 2025 as against Rs 20.27 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales34.1820.27 69 OPM %-1.64-11.64 - PBDT1.763.28 -46 PBT1.232.62 -53 NP0.811.66 -51 Powered by Capital Market - Live

4 months agoCapital Market - Live
Corporate
Nureca to conduct board meeting

Nureca will hold a meeting of the Board of Directors of the Company on 15 July 2025.Powered by Capital Market - Live

4 months agoCapital Market - Live
Corporate
Nureca schedules AGM

Nureca announced that the 9th Annual General Meeting(AGM) of the company will be held on 16 June 2025.Powered by Capital Market - Live

7 months agoCapital Market - Live
Earnings
Nureca reports consolidated net profit of Rs 2.47 crore in the March 2025 quarter

Net profit of Nureca reported to Rs 2.47 crore in the quarter ended March 2025 as against net loss of Rs 4.15 crore during the previous quarter ended March 2024. Sales rose 87.04% to Rs 31.74 crore in the quarter ended March 2025 as against Rs 16.97 crore during the previous quarter ended March 2024. For the full year,net profit reported to Rs 0.85 crore in the year ended March 2025 as against net loss of Rs 1.79 crore during the previous year ended March 2024. Sales rose 19.29% to Rs 109.66 crore in the year ended March 2025 as against Rs 91.93 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales31.7416.97 87 109.6691.93 19 OPM %3.78-26.10 --6.88-11.10 - PBDT2.57-5.87 LP 3.68-0.18 LP PBT2.05-6.47 LP 1.34-2.54 LP NP2.47-4.15 LP 0.85-1.79 LP Powered by Capital Market - Live

7 months agoCapital Market - Live

Frequently asked questions

Frequently asked questions

  1. What is the share price of Nureca Ltd (NURECA) today?

    The share price of NURECA as on 5th December 2025 is ₹305.50. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.

  2. What is the return on Nureca Ltd (NURECA) share?

    The past returns of Nureca Ltd (NURECA) share are
    • Past 1 week: 8.39%
    • Past 1 month: 13.65%
    • Past 3 months: 18.83%
    • Past 6 months: 7.84%
    • Past 1 year: 4.39%
    • Past 3 years: -40.63%
    • Past 5 years: -52.69%

  3. What are the peers or stocks similar to Nureca Ltd (NURECA)?

    The peers or stocks similar to Nureca Ltd (NURECA) include:

  4. What is the market cap of Nureca Ltd (NURECA) share?

    Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Nureca Ltd (NURECA) is ₹305.51 Cr as of 5th December 2025.

  5. What is the 52 week high and low of Nureca Ltd (NURECA) share?

    The 52-week high of Nureca Ltd (NURECA) is ₹447.50 and the 52-week low is ₹203.62.

  6. What is the PE and PB ratio of Nureca Ltd (NURECA) stock?

    The P/E (price-to-earnings) ratio of Nureca Ltd (NURECA) is 355.24. The P/B (price-to-book) ratio is 1.57.

  7. Which sector does Nureca Ltd (NURECA) belong to?

    Nureca Ltd (NURECA) belongs to the Health Care sector & Pharmaceuticals sub-sector.

  8. How to buy Nureca Ltd (NURECA) shares?

    You can directly buy Nureca Ltd (NURECA) shares on Tickertape. Simply sign up, connect your demat account and place your order.